Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             208 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal creases in the hand-prints of schizophrenic patients Cannon, M.
 1992
 6 2 p. 105-
1 p.
 artikel
2 A case control study of schizophrenia and ethnicity: 1964–1984 Wessely, S.
 1992
 6 2 p. 103-
1 p.
 artikel
3 A comparison of diagnosis and treatment in black and white acute psychiatric inpatients, with particular reference to major psychotic illness Boddington, J.D.
 1992
 6 2 p. 102-103
2 p.
 artikel
4 A double-blind comparison of acute buprenorphine with placebo in schizophrenia Nutt, D.J.
 1992
 6 2 p. 113-
1 p.
 artikel
5 A follow-back study of schizophrenia and affective disorder: Pre-psychotic cognitive abnormalities in schizophrenia Jones, P.B.
 1992
 6 2 p. 159-160
2 p.
 artikel
6 Age, gender, period and cohort effects on the season of birth in schizophrenia Klæning, U.
 1992
 6 2 p. 101-
1 p.
 artikel
7 Alcohol use in schizophrenia: Symptomatology, relationship with tardive dyskinesia and age at onset Duke, P.J.
 1992
 6 2 p. 122-
1 p.
 artikel
8 A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11 Gill, M.
 1992
 6 2 p. 89-
1 p.
 artikel
9 All-night EEG sleep in drug naive patients with a first episode of schizophrenia Lauer, C.J.
 1992
 6 2 p. 125-126
2 p.
 artikel
10 Alpha-tocopherol attenuates the development of neuroleptic-induced dopaminergic hypersensitivity in rats. Implications for tardive dyskinesia Gattaz, W.F.
 1992
 6 2 p. 117-118
2 p.
 artikel
11 Alpha-tocopherol in the treatment of tardive dyskinesia Junker, D.
 1992
 6 2 p. 122-123
2 p.
 artikel
12 Altered brain structure in schizophrenia: A postmortem stereological study Royston, M.C.
 1992
 6 2 p. 155-
1 p.
 artikel
13 Altered information processing in schizophrenia during sleep Aldenhoff, J.B.
 1992
 6 2 p. 125-
1 p.
 artikel
14 Alternative treatments for non-responding patients Kane, J.M.
 1992
 6 2 p. 108-109
2 p.
 artikel
15 Alzheimer's disease in aging schizophrenics and the ultrastructure of cortical synapses in schizophrenia Šoustek, Z.
 1992
 6 2 p. 154-
1 p.
 artikel
16 Analysis of gene expression in schizophrenia by in situ hybridization de Belleroche, J.
 1992
 6 2 p. 154-155
2 p.
 artikel
17 An association study of schizophrenia and the porphobilinogen deaminase gene alleles Nimgaonkar, V.L.
 1992
 6 2 p. 90-91
2 p.
 artikel
18 Anterior corpus callosal size and frontal lobe function in MRI and 31p MRS studies Saunders, R.D.
 1992
 6 2 p. 146-
1 p.
 artikel
19 Antibrain antibodies in sera of schizophrenic patients Henneberg, A.E.
 1992
 6 2 p. 141-
1 p.
 artikel
20 A one-year dose reduction study in chronic schizophrenic inpatients: Amisulpride vs haloperidol Barnes, T.R.E.
 1992
 6 2 p. 107-
1 p.
 artikel
21 A pilot MRI study of adolescents suffering from psychosis Schulz, S.C.
 1992
 6 2 p. 144-
1 p.
 artikel
22 Are schizophrenia and affective disorders related in families? A replication study Maier, W.
 1992
 6 2 p. 166-
1 p.
 artikel
23 A search for relationships between the month of birth of schizophrenics and population mortality from measles and influenza in Scotland and England Adams, W.
 1992
 6 2 p. 99-
1 p.
 artikel
24 Assessment of vitamins and coenzymes involved in catecholamine metabolism in schizophrenic patients with and without neuroleptic treatment Ramchand, C.N.
 1992
 6 2 p. 119-
1 p.
 artikel
25 Attributional style and negative symptoms in chronic schizophrenic patients Sullivan, T.B.
 1992
 6 2 p. 168-
1 p.
 artikel
26 Atypical profile of remoxipride after subchronic administration in the rat Köhler, C.
 1992
 6 2 p. 116-117
2 p.
 artikel
27 Auditory evoked potentials in schizophrenic patients before and during neuroleptic treatment. Relationship to psychopathological state Adler, G.
 1992
 6 2 p. 128-
1 p.
 artikel
28 Author index 1992
 6 2 p. 177-180
4 p.
 artikel
29 Autoimmune phenomena in schizophrenic patients Ganguli, R.
 1992
 6 2 p. 140-141
2 p.
 artikel
30 Axon count in nucleus accumbens in schizophrenia Stevens, J.R.
 1992
 6 2 p. 154-
1 p.
 artikel
31 Behavioral correlates of sensorimotor gating: Exploratory activity and prepulse inhibition of startle Smith, D.A.
 1992
 6 2 p. 163-
1 p.
 artikel
32 Benign neutropenia induced by clozapine Hummer, M.
 1992
 6 2 p. 116-
1 p.
 artikel
33 Blood polyamines in schizophrenia: A study of clozapine in drug resistant schizophrenic patients Das, I.
 1992
 6 2 p. 175-
1 p.
 artikel
34 Brain morphology in schizophrenia: A prospective longitudinal study DeLisi, L.E.
 1992
 6 2 p. 143-144
2 p.
 artikel
35 Can cerebral venticular enlargement predict progression of first-episode acute schizophreniform disorder in schizophrenia? Vita, A.
 1992
 6 2 p. 150-151
2 p.
 artikel
36 Can the epidemiology of schizophrenia be explained by variation in maternal influenza? Murray, R.M.
 1992
 6 2 p. 98-
1 p.
 artikel
37 Changes in erythrocyte membrane permeability associated with neuroleptic medication in schizophrenic patients Ramchand, C.N.
 1992
 6 2 p. 119-
1 p.
 artikel
38 Childhood antecedents of schizophrenia and affective disorder — A prospective study Done, D.John
 1992
 6 2 p. 105-
1 p.
 artikel
39 Childhood development and schizophrenia Zeitlin, H.
 1992
 6 2 p. 160-
1 p.
 artikel
40 Cholinergic mechanisms and REM sleep abnormalities in schizophrenia Tandon, R.
 1992
 6 2 p. 126-127
2 p.
 artikel
41 Cholinergic stimulation and REM sleep in depression and schizophrenia Riemann, D.
 1992
 6 2 p. 126-
1 p.
 artikel
42 Classifying schizophrenia into neurodevelopmental and adult onset forms Murray, R.M.
 1992
 6 2 p. 170-
1 p.
 artikel
43 Clopenthixol treatment of schizophrenia increases dopamine D1 receptor density Reynolds, G.P.
 1992
 6 2 p. 137-
1 p.
 artikel
44 Clozapine induced neutropenia as an effect of decreased cytokine release Sperner-Unterweger, B.
 1992
 6 2 p. 116-
1 p.
 artikel
45 Clozapine in treatment resistant schizophrenia Verhoeven, W.M.A.
 1992
 6 2 p. 113-
1 p.
 artikel
46 Compelling evidence for orbito-frontal glutamatergic dysfunction in schizophrenic brain Deakin, J.F.W.
 1992
 6 2 p. 133-
1 p.
 artikel
47 Compliance in schizophrenic patients Noble, P.
 1992
 6 2 p. 108-
1 p.
 artikel
48 Concordance by sex as a general finding in schizophrenia and bipolar disorder — What is the explanation? Crow, T.J.
 1992
 6 2 p. 95-
1 p.
 artikel
49 Confirmatory and disconfirmatory feedback in the communication between parents of schizophrenics, pathological controls and normal offspring Wichstrøm, l.
 1992
 6 2 p. 173-
1 p.
 artikel
50 Contents 1992
 6 2 p. iii-
1 p.
 artikel
51 Controlled study on time perception of schizophrenic and depressive patients Bidzan, Leszek
 1992
 6 2 p. 161-
1 p.
 artikel
52 CSF levels of diazepam binding-inhibitor correlate with rem latency and slow wave sleep in schizophrenia Peters, J.L.
 1992
 6 2 p. 126-
1 p.
 artikel
53 Decreased sensitivity to light in negative schizophrenia Gerbaldo, H.
 1992
 6 2 p. 167-
1 p.
 artikel
54 Dementia in elderly schizophrenics Davidson, M.
 1992
 6 2 p. 161-162
2 p.
 artikel
55 Depressive states at the onset of juvenile schizophrenia Vladimirova, T.V.
 1992
 6 2 p. 171-
1 p.
 artikel
56 Diagnostic criteria for schizoaffective disorder: The importance of polarity for predictive validity Lenz, G.
 1992
 6 2 p. 165-166
2 p.
 artikel
57 Different capability of NMDA antagonists to elicit phencyclidine-like EEG and behavioural effects in rats Sagratella, S.
 1992
 6 2 p. 133-
1 p.
 artikel
58 Diffuse structural brain abnormalities in schizophrenia Ron, M.A.
 1992
 6 2 p. 145-
1 p.
 artikel
59 Disorder of attention in individuals with schizotypal personality: Switching attention across sensory modalities Wilkins, S.
 1992
 6 2 p. 159-
1 p.
 artikel
60 Disturbances in motor dexterity performance of schizophrenic patients as predictor for the manifestation of extrapyramidal side effects during neuroleptic treatment Steigleider, P.
 1992
 6 2 p. 123-124
2 p.
 artikel
61 DNA repair and mutant frequency in schizophrenia Alexander, R.C.
 1992
 6 2 p. 96-
1 p.
 artikel
62 Dopamine autoreceptor agonists are not clinically effective in acute schizophrenia. Implications for the dopamine hypothesis Klimke, A.
 1992
 6 2 p. 112-
1 p.
 artikel
63 Dopamine D2 receptor changes in the pallidum: Their relationship with antipsychotic drug treatment and dyskinesias in schizophrenia Reynolds, G.P.
 1992
 6 2 p. 137-
1 p.
 artikel
64 Dopaminergic correlates of attentional performance in unmedicated schizophrenic patients Harvey, P.D.
 1992
 6 2 p. 136-
1 p.
 artikel
65 Do schizophrenics act on their delusions? Wessely, S.
 1992
 6 2 p. 169-
1 p.
 artikel
66 DRD2 (TGn) repeat polymorphism in a large family data set Shaikh, S.
 1992
 6 2 p. 91-
1 p.
 artikel
67 DSMIIIR personality disorders of the schizophrenic spectrum as evidenced by family studies Lichtermann, D.
 1992
 6 2 p. 165-
1 p.
 artikel
68 Early onset schizophrenia: A preponderance of males with severe illness associated with premorbid dysfunction Castle, D.J.
 1992
 6 2 p. 103-104
2 p.
 artikel
69 EEG alterations in patients treated with clozapine in relation to plasma levels Haring, C.
 1992
 6 2 p. 128-129
2 p.
 artikel
70 Effect of atypical and typical antipsychotic drugs on neuropsychological functions in early-stage schizophrenic patients Kenny, JohnT.
 1992
 6 2 p. 162-
1 p.
 artikel
71 Effect of haloperidol on CSF monoamine metabolites in schizophrenia. Symptomatic improvement is related to altered dopamine-serotonin interaction Kahn, R.S.
 1992
 6 2 p. 118-
1 p.
 artikel
72 Effect of repeated neuroleptic treatment on spontaneously active dopamine neurons in the VTA and SNC area in rats. Correlation to antipsychotic activity in the clinic? Skarsfeldt, T.
 1992
 6 2 p. 117-
1 p.
 artikel
73 Effect of season of birth on schizophrenic cortical volumes measured on MRI Persaud, R.D.
 1992
 6 2 p. 145-146
2 p.
 artikel
74 Effects of an ambulant group therapy program on psychosocial adaptation of chronic schizophrenic outpatients Bruns, U.
 1992
 6 2 p. 175-
1 p.
 artikel
75 Effects of neuroleptic therapy on phospholipid metabolism in schizophrenia Steudle, A.
 1992
 6 2 p. 118-
1 p.
 artikel
76 Effects of the menstrual cycle on therapeutic response in schizophrenic patients Vogel, P.
 1992
 6 2 p. 115-
1 p.
 artikel
77 Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of schizophrenic patients Wahlbeck, Kristian
 1992
 6 2 p. 139-
1 p.
 artikel
78 Elevated dopamine 2 receptor density in 23 schizophrenic patients: A positron emission tomography study with [11C]N- methylspiperone Tune, LarryE.
 1992
 6 2 p. 147-
1 p.
 artikel
79 Elevated postimperative negative variation and electrodermal unresponsiveness in chronic schizophrenia Eikmeier, G.
 1992
 6 2 p. 128-
1 p.
 artikel
80 Estradiol attenuates dopamine-mediated behavior in rats. Implications for sex differences in schizophrenia Behrens, S.
 1992
 6 2 p. 114-
1 p.
 artikel
81 Evidence for confinement of winter birth excess in schizophrenia to those born in cities O'Callaghan, E.
 1992
 6 2 p. 102-
1 p.
 artikel
82 Evidence for decline in schizophrenia de Alarcon, J.
 1992
 6 2 p. 100-
1 p.
 artikel
83 Evidence for increased fertility in married male schizophrenics Lane, A.
 1992
 6 2 p. 94-
1 p.
 artikel
84 Evidence for sensitization in the early stage of schizophrenia Lieberman, J.A.
 1992
 6 2 p. 109-
1 p.
 artikel
85 Expressed emotion and relapse rates in schizophrenic patients Cohen, R.
 1992
 6 2 p. 172-173
2 p.
 artikel
86 Extrapyramidal side effects of clozapine Fleischhacker, W.W.
 1992
 6 2 p. 115-116
2 p.
 artikel
87 Fetal drug exposure: A potential animal model of schizophrenia Lyon, M.
 1992
 6 2 p. 139-
1 p.
 artikel
88 Frontal functioning and plasma HVA in the relatives of schizophrenic patients Keefe, R.S.E.
 1992
 6 2 p. 158-
1 p.
 artikel
89 Frontal lobe impairment in schizophrenia Okocha, I.
 1992
 6 2 p. 158-159
2 p.
 artikel
90 Frontal rCBF in schizophrenia. Wisconsin card sorting task compared with control task of matched complexity Reischies, F.M.
 1992
 6 2 p. 149-
1 p.
 artikel
91 GABA-A receptor subunit genes. An association analysis Walsh, Catherine
 1992
 6 2 p. 92-
1 p.
 artikel
92 Gender differences in the presentation, course, and outcome of first episode schizophrenics Szymanski, Sally
 1992
 6 2 p. 104-105
2 p.
 artikel
93 Genetic linkage analysis of schizophrenia using microsatellite repeat polymorphisms on chromosome 12 Dawson, E.
 1992
 6 2 p. 90-
1 p.
 artikel
94 Histories of obstetric complications and neonatal abnormalities in monozygotic twins concordant and discordant for schizophrenia McNeil, T.
 1992
 6 2 p. 106-
1 p.
 artikel
95 Immunological measurements in patients with schizophreniform psychosis Wieselmann, G.
 1992
 6 2 p. 141-142
2 p.
 artikel
96 Increased lysophosphatidylcholine content in platelet membrane of schizophrenics Pangerl, A.M.
 1992
 6 2 p. 134-135
2 p.
 artikel
97 Increased phospholipase A2 activity in schizophrenia Gattaz, W.F.
 1992
 6 2 p. 135-
1 p.
 artikel
98 Increased prevalence of the cavum septum pellucidum in MRI scans and postmortem brains of schizophrenic patients Degreef, G.
 1992
 6 2 p. 145-
1 p.
 artikel
99 Interleukins 1, 2 and 6 in the plasma of neuroleptic-free and treated schizophrenic patients and their relatives Wei, J.
 1992
 6 2 p. 140-
1 p.
 artikel
100 Intrinsic activity of dopamine D2 agonists determined from receptor binding affinites. Correlation with in vivo activity Lahti, R.A.
 1992
 6 2 p. 117-
1 p.
 artikel
101 In-vivo dopamine D2 receptor density in psychotic and non-psychotic bipolar patients Pearlson, GodfreyD.
 1992
 6 2 p. 147-
1 p.
 artikel
102 In vivo proton magnetic resonance spectroscopy (MRS) of the hippocampus/amygdala region in schizophrenia Nasrallah, H.A.
 1992
 6 2 p. 150-
1 p.
 artikel
103 Is the incidence of schizophrenia falling? Kendell, R.E.
 1992
 6 2 p. 100-101
2 p.
 artikel
104 Left hippocampal dysfunction in catatonic syndromes measured with spect Ebert, D.
 1992
 6 2 p. 149-
1 p.
 artikel
105 Linkage analysis and sib pair test for linkage of schizophrenia with D11S35 Lehner, T.
 1992
 6 2 p. 92-
1 p.
 artikel
106 Linkage analysis of schizophrenia on chromosome 22 Collier, DavidA.
 1992
 6 2 p. 89-90
2 p.
 artikel
107 Locus of control in specific situations in chronic schizophrenia Lasar, M.
 1992
 6 2 p. 162-
1 p.
 artikel
108 Longitudinal studies of AERPS and clinical evolution of thought disorders and positive/negative symptoms in schizophrenia Laurent, J.-P.
 1992
 6 2 p. 129-
1 p.
 artikel
109 Loosening of association, thought disorder and delusions Mortimer, A.M.
 1992
 6 2 p. 169-
1 p.
 artikel
110 Loss of sylvian fissure asymmetry in schizophrenia: Findings in the runwell 2 series of brains Crow, T.J.
 1992
 6 2 p. 152-153
2 p.
 artikel
111 Management of risk of relapse in schizophrenia Wirshing, W.C.
 1992
 6 2 p. 107-108
2 p.
 artikel
112 m-chlorophenylpiperazine as a probe of serotonin function in schizophrenia Kahn, R.S.
 1992
 6 2 p. 138-
1 p.
 artikel
113 Membrane essential fatty acids (EFAS) show a biphasic distribution in schizophrenics with predominantly positive or predominantly negative symptoms Horrobin, D.F.
 1992
 6 2 p. 135-136
2 p.
 artikel
114 Membrane phospholipids and lithium response in schizophrenia: A 31P MRS study Keshavan, M.S.
 1992
 6 2 p. 134-
1 p.
 artikel
115 Memory impairment in schizophrenia. Clues to the underlying brain malfunction Al-Eithan, Muwafak
 1992
 6 2 p. 156-157
2 p.
 artikel
116 Metabolism of catecholamines in schizophrenic patients and their relatives Wei, J.
 1992
 6 2 p. 138-
1 p.
 artikel
117 Methodologic issues in P50 sensory gating Lamberti, J.S.
 1992
 6 2 p. 164-
1 p.
 artikel
118 Mode of inheritance in schizophrenia. Analysis of models for linkage studies Alda, M.
 1992
 6 2 p. 94-
1 p.
 artikel
119 Morbid risk of schizophrenia among relatives of patients with cannabis-associated psychosis McGuire, P.K.
 1992
 6 2 p. 93-94
2 p.
 artikel
120 Natural vs formal logic and disordered thought in schizophrenia de Bonis, M.
 1992
 6 2 p. 157-
1 p.
 artikel
121 Neurochemical abnormalities of the cerebral cortex in schizophrenia Simpson, M.D.C.
 1992
 6 2 p. 133-134
2 p.
 artikel
122 Neurological soft signs: Group differences and correlates Mohr, F.
 1992
 6 2 p. 169-170
2 p.
 artikel
123 Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects Kahn, R.S.
 1992
 6 2 p. 125-
1 p.
 artikel
124 Novel neuroleptic dosage reduction strategies Carpenter, W.T.
 1992
 6 2 p. 107-
1 p.
 artikel
125 Obstetric complications in severe psychosis Honer, W.G.
 1992
 6 2 p. 105-106
2 p.
 artikel
126 Ondansetron. A double blind placebo controlled study in acute schizophrenia McBain, S.L.
 1992
 6 2 p. 112-
1 p.
 artikel
127 Ondansetron attenuates the psychological, but not the psychomotor effects of amphetamine Silverstone, P.H.
 1992
 6 2 p. 119-120
2 p.
 artikel
128 On silent schizoprenia: Negative symptoms and language impairment Stanghellini, G.
 1992
 6 2 p. 167-
1 p.
 artikel
129 ORG 10490: A new antipsychotic drug with 5-HT2 and DA antagonistic properties Bruin, R.J.
 1992
 6 2 p. 111-
1 p.
 artikel
130 P300 amplitude decrements and global personality functional deficits Squires-Wheeler, E.
 1992
 6 2 p. 131-
1 p.
 artikel
131 Paranoid schizophrenics may not use irrelevant signals: Conditioned blocking and urinary measures of dopamine activity Oades, R.D.
 1992
 6 2 p. 162-163
2 p.
 artikel
132 Patterns of negative symptoms and the course of schizophrenia Gerbaldo, H.
 1992
 6 2 p. 166-167
2 p.
 artikel
133 Planum temporale in schizophrenia: A magnetic resonance study Rossi, A.
 1992
 6 2 p. 143-
1 p.
 artikel
134 Plasma homovanillic acid and the deficit/nondeficit forms of schizophrenia Ribeyre, J.M.
 1992
 6 2 p. 137-138
2 p.
 artikel
135 Poor scholastic achievement and premorbid social decline in schizophrenia Jones, P.B.
 1992
 6 2 p. 160-
1 p.
 artikel
136 Positive and negative syndromes in schizophrenia: A clinical-neuropsychophysiological approach Soliman, H.S.
 1992
 6 2 p. 131-132
2 p.
 artikel
137 Preference for denotative as opposed to connotative meanings in schizophrenics Cutting, J.C.
 1992
 6 2 p. 157-158
2 p.
 artikel
138 Preliminary characterization of a novel dopamine binding site Copolov, D.L.
 1992
 6 2 p. 136-
1 p.
 artikel
139 Prescription of neuroleptics to out-patients: A pharmacoepidemiologic study Diana, G.
 1992
 6 2 p. 108-
1 p.
 artikel
140 Preserved procedural and implicit memory in schizophrenia further evidence for an amnesic syndrome pattern of impairment Clare, L.
 1992
 6 2 p. 156-
1 p.
 artikel
141 Prevalence and severity of neuroleptic-induced extrapyramidal side effects in schizophrenia and delusional disorder. Relationships with diagnosis Di Rosa, M.
 1992
 6 2 p. 121-122
2 p.
 artikel
142 Prevalence and time course of neuroleptic-induced akathisia Casey, D.E.
 1992
 6 2 p. 121-
1 p.
 artikel
143 Prolonged T2 relaxation time in schizophrenia and its relationship to lateral ventricular volume on MRI Buckley, P.
 1992
 6 2 p. 146-147
2 p.
 artikel
144 Psychophysiological characteristics in schizophrenics and the risk for psychotic episodes Olbrich, Robert
 1992
 6 2 p. 129-130
2 p.
 artikel
145 Psychosis and epilepsy: Clinicopathological correlations Bruton, C.J.
 1992
 6 2 p. 154-
1 p.
 artikel
146 Quality of life assessments in clinical trials of neuroleptics— conceptual issues and current status Awad, A.G.
 1992
 6 2 p. 172-
1 p.
 artikel
147 Quantitative image analysis in the determination of sulco-gyral pattern variations in the temporal lobe of schizophrenics Roberts, G.W.
 1992
 6 2 p. 153-
1 p.
 artikel
148 Quantitative neurobehavioural examination Cleghorn, J.M.
 1992
 6 2 p. 161-
1 p.
 artikel
149 Ratings of negative symptoms: Components and correlations Werther, P.
 1992
 6 2 p. 168-
1 p.
 artikel
150 Reduced sylvian fissure and planum temporale asymmetry in schizophrenia. Evidence for disturbed left hemispheric neurodevelopment? Falkai, P.
 1992
 6 2 p. 152-
1 p.
 artikel
151 Relating age of onset to age of first admission in schizophrenia Pemberton, M.R.
 1992
 6 2 p. 104-
1 p.
 artikel
152 Relationship between event-related potential measures of information processing and positive and negative symptoms Ward, P.B.
 1992
 6 2 p. 131-
1 p.
 artikel
153 Remoxipride and haloperidol in the treatment of acute phase schizophrenia Lewander, T.
 1992
 6 2 p. 110-
1 p.
 artikel
154 Reversibility and irreversibility of tardive dyskinesia following neuroleptic withdrawal Lahti, A.C.
 1992
 6 2 p. 123-
1 p.
 artikel
155 RFLP linkage study in schizophrenia on chromosome 2 Aschauer, H.N.
 1992
 6 2 p. 89-
1 p.
 artikel
156 Role of neuroleptic drugs and organic mechanisms in the aetiology of menstrual irregularities in schizophrenic women Prentice, D.S.
 1992
 6 2 p. 114-
1 p.
 artikel
157 Schizophrenia and chromosomal fragile sites Garofalo, G.
 1992
 6 2 p. 93-
1 p.
 artikel
158 Schizophrenia and the 1957 influenza epidemic Torrey, E.Fuller
 1992
 6 2 p. 100-
1 p.
 artikel
159 Schizophrenia in Afro-Caribbeans in the U.K. following prenatal exposure to the 1957 A2 influenza epidemic Fahy, T.A.
 1992
 6 2 p. 98-99
2 p.
 artikel
160 Schizophrenia is not due to maternal influenza in the second (or other) trimester of pregnancy Crow, T.J.
 1992
 6 2 p. 99-100
2 p.
 artikel
161 Schizophrenic symptomatology varies with serum estradiol levels during menstrual cycle Riecher-Rössler, Anita
 1992
 6 2 p. 114-115
2 p.
 artikel
162 Selegiline in the treatment of akathisia, tardive dyskinesia, and negative schizophrenic symptoms Ames, D.
 1992
 6 2 p. 110-111
2 p.
 artikel
163 Semantic memory impairment in schizophrenia McKenna, P.J.
 1992
 6 2 p. 156-
1 p.
 artikel
164 Sertindole, a novel atypical neuroleptic drug candidate: safety and tolerance in normal human subjects Friberg, H.H.
 1992
 6 2 p. 111-112
2 p.
 artikel
165 Serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia: Failure to detect abnormalities Dalgalarrondo, P.
 1992
 6 2 p. 140-
1 p.
 artikel
166 Sex chromosome anomalies and schizophrenia DeLisi, LynnE.
 1992
 6 2 p. 92-93
2 p.
 artikel
167 Sex concordance for schizophrenia in families Maier, W.
 1992
 6 2 p. 95-96
2 p.
 artikel
168 Significant decrease in psychopathology within three days of haloperidol treatment in chronic schizophrenia Stern, R.G.
 1992
 6 2 p. 109-110
2 p.
 artikel
169 Sleep disturbances in schizophrenia: Effects of haloperidol van Kammen, D.P.
 1992
 6 2 p. 127-
1 p.
 artikel
170 Smooth pursuit eye movement deficits in schizophrenic patients: Symptomatic, neurological, and neuropsychological correlates Schlenker, R.
 1992
 6 2 p. 130-
1 p.
 artikel
171 Supervisory mental processes in schizophrenia: A study using PET Liddle, P.F.
 1992
 6 2 p. 148-
1 p.
 artikel
172 Tardive dyskinesia: Recognition and quantification by means of digital image processing Büchel, C.
 1992
 6 2 p. 121-
1 p.
 artikel
173 T-cell subsets in schizophrenic patients Sperner-Unterweger, B.
 1992
 6 2 p. 141-
1 p.
 artikel
174 Temporal limbic structure volumes and psychopathology in chronic schizophrenia Bogerts, B.
 1992
 6 2 p. 143-
1 p.
 artikel
175 Temporal lobe activation during verbal memory challenge. A spet study Busatto, G.
 1992
 6 2 p. 148-149
2 p.
 artikel
176 Temporal stability and predictive validity of diagnostic criteria for schizophrenia Lenz, G.
 1992
 6 2 p. 170-
1 p.
 artikel
177 The camden schizophrenia surveys: Chronic mental illness in primary care Harvey, C.
 1992
 6 2 p. 174-
1 p.
 artikel
178 The concurrent assessment of sustained attention and concept formation in remitted schizophrenics: Performance scores and signal detection indices Mussgay, L.
 1992
 6 2 p. 159-
1 p.
 artikel
179 The contribution of life events to schizophrenic relapse. An event history analysis Hirsch, S.R.
 1992
 6 2 p. 172-
1 p.
 artikel
180 The criminal careers of incident cases of schizophrenia Wessely, S.
 1992
 6 2 p. 174-
1 p.
 artikel
181 The declining incidence of schizophrenia in a rural irish population of unusual homogeneity: Secular trend towards early onset and male preponderance Waddington, JohnL.
 1992
 6 2 p. 101-
1 p.
 artikel
182 The deficit state in a prospective study of first-episode schizophrenia Mayerhoff, D.I.
 1992
 6 2 p. 168-169
2 p.
 artikel
183 The dimensional complexity of the EEG in untreated acute schizophrenics, in persons in remission after a first schizophrenic episode, and in controls Koukkou, M.
 1992
 6 2 p. 129-
1 p.
 artikel
184 The effect of apomorphine on regional cerebral blood flow in normal volunteers Grasby, P.
 1992
 6 2 p. 149-
1 p.
 artikel
185 The function of the brussels night hospital: Dumping, recycling or container? De Hert, M.
 1992
 6 2 p. 173-
1 p.
 artikel
186 The impact of sex, age at onset and birth complications on the risk of schizophrenia in a family study sample Maier, W.
 1992
 6 2 p. 96-
1 p.
 artikel
187 The incidence of cancer in first admitted schizophrenic patients Mortensen, P.B.
 1992
 6 2 p. 106-
1 p.
 artikel
188 The incidence of neuroleptic-induced akathisia Oberbauer, H.
 1992
 6 2 p. 123-
1 p.
 artikel
189 The neuroanatomy of the deficit syndrome Carpenter, W.T.
 1992
 6 2 p. 166-
1 p.
 artikel
190 The neurobiology of dysfunctional receptive and expressive social communication in schizophrenia Whittaker, J.F.
 1992
 6 2 p. 163-
1 p.
 artikel
191 The neuroleptic threshold dose for acute schizophrenia McEvoy, J.P.
 1992
 6 2 p. 109-
1 p.
 artikel
192 The neuropsychology of thought disorder McGrath, J.J.
 1992
 6 2 p. 157-
1 p.
 artikel
193 Therapeutic alliance in treatment: Refractory schizophrenia Grimaldi, J.A.
 1992
 6 2 p. 173-174
2 p.
 artikel
194 The relationship between prenatal exposure to influenza and later schizophrenia over 22 years Sham, P.
 1992
 6 2 p. 98-
1 p.
 artikel
195 The relationship of PET D2 dopamine receptor findings to superior temporal gyral volume estimates in 14 schizophrenic subjects Tune, LarryE.
 1992
 6 2 p. 147-148
2 p.
 artikel
196 The search for an endophenotype correlated with a subtype of schizophrenia: Magnetic resonance imaging in two large British Pedigrees Sharma, T.
 1992
 6 2 p. 96-97
2 p.
 artikel
197 The specificity of schizoptypal symptoms to schizophrenia Birkett, P.B.L.
 1992
 6 2 p. 165-
1 p.
 artikel
198 The syndrome of acute hallucinosis in schizophrenia Nickiforova, I.Iu.
 1992
 6 2 p. 170-171
2 p.
 artikel
199 The use of electrophysiological markers in linkage analysis in schizophrenic and bipolar pedigrees Sharp, C.W.
 1992
 6 2 p. 130-131
2 p.
 artikel
200 The VIth Biennial European workshop on schizophrenia DeLisi, Lynn E.
 1992
 6 2 p. iv-
1 p.
 artikel
201 Treatment of the neuroleptic malignant syndrome with ECT De Hert, M.
 1992
 6 2 p. 111-
1 p.
 artikel
202 Ultrastructural features of temporopolar cortex (area 38) in a case of schizophrenia Garey, L.J.
 1992
 6 2 p. 153-
1 p.
 artikel
203 Urban-rural differences in place of upbringing and later schizophrenia David, A.S.
 1992
 6 2 p. 101-102
2 p.
 artikel
204 VBR and adolescent onset of schizophrenia Lee, Friedman
 1992
 6 2 p. 144-145
2 p.
 artikel
205 Ventricular size and regional cerebral blood flow in schizophrenia Ford, R.A.
 1992
 6 2 p. 150-
1 p.
 artikel
206 What can monozygotic twins tell us about schizophrenia? Torrey, E.F.
 1992
 6 2 p. 94-95
2 p.
 artikel
207 Why is the onset of schizophrenia later in women? Häfner, H.
 1992
 6 2 p. 104-
1 p.
 artikel
208 Winter birth excess in schizophrenia: Its relationship to place of birth Takei, N.
 1992
 6 2 p. 102-
1 p.
 artikel
                             208 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland